Mark Turco, MD is an experienced scientific and business development executive with cross-industry expertise, who joined the University of Pennsylvania as the Chief Innovation and Corporate Outreach Officer in January 2017. Dr. Turco provides expertise for the University of Pennsylvania leaders, building relationships and partnerships with both internal and external clinicians, faculty and thought leaders, as part of the University’s efforts to expand innovation and translational opportunities regionally, nationally and globally. He is responsible for helping to successfully orchestrate external commercial partnerships for Penn-based technologies and inventions across all sectors of biopharma, med device, digital health and consumer-based products, as well as developing industry-academic partnerships to further the University’s efforts around innovation.
Dr. Turco spent 7 years working for large cap medical device companies, serving as Vice President and Chief Medical Officer of the vascular and neuro franchises for Medtronic, Inc. and Covidien, plc. In these roles, he informed strategy for complex business decisions regarding technologies and programs that encompassed patient considerations, clinical trial design, regulatory processes, physician training, evolving healthcare systems and value-based models—both domestically and internationally. He also evaluated opportunities for growth and investment through medical, business, payers, providers, and regulators lenses and was integral to the evaluation of new business development prospects along with gaining valuable insight from key opinion leaders in the field though the development of high level strategic advisory boards. Dr. Turco was instrumental in helping to build out Covidien’s vascular platform, which was subsequently a key component of Medtronic’s acquisition of Covidien.
After receiving an undergraduate degree from the University of Pennsylvania, Dr. Turco received his medical degree and internal medicine training at the George Washington University in Washington, D.C. and performed his cardiology training at Temple University Hospital and at Penn Presbyterian Medical Center in Philadelphia. He practiced as an interventional cardiologist in the Washington, D.C. area for 16 years, serving as Director of the Cardiovascular Research Center at Washington Adventist Hospital and maintained an active patient care practice across all fields of cardiovascular disease and responsible for clinical trial leadership as a regional and global principal investigator for large industry sponsored drug and device trials. Keys areas of academic interest and research were in the fields of cardiac arrest and cardiogenic shock, acute myocardial infarction, drug device delivery, embolic protection and structural or valvular heart disease. As a practicing cardiologist, Dr. Turco also played a role in the development from concept to commercialization of several medical devices currently being utilized in the field of cardiovascular medicine.